LGND
Ligand Pharmaceuticals
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: LGND
- PE Ratio
As of Jun 23, 2026, the Ligand Pharmaceuticals stock's PE ratio is 35.37. This results from the current EPS of $7.9 and stock price of $279.44.
LGND PE ratio history
The PE ratio of Ligand Pharmaceuticals has averaged 90.07 over the last ten years. The current PE ratio of 35.37 is 61% below the historical average. Over the past ten years, LGND's PE ratio was at its highest in the Sep 2020 quarter at 794.33, when the stock price was $95.32 and the EPS was $0.12. The lowest value was in the Dec 2019 quarter, when it reached 3.15 with a price of $104.29 and an EPS of $33.13.
Ligand Pharmaceuticals PE ratio by year
Maximum annual decrease: -91.22% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 29.36 | N/A | $189.07 | $6.44 |
| 2024 | N/A | N/A | $107.15 | -$0.22 |
| 2023 | 23.65 | N/A | $71.42 | $3.02 |
| 2022 | N/A | N/A | $66.8 | -$1.98 |
| 2021 | 44.9 | N/A | $154.46 | $3.44 |
| 2020 | N/A | N/A | $99.45 | -$0.18 |
| 2019 | 3.15 | -84.28% | $104.29 | $33.13 |
| 2018 | 20.04 | -91.22% | $135.7 | $6.77 |
| 2017 | 228.22 | N/A | $136.93 | $0.6 |
| 2016 | N/A | N/A | $101.61 | -$0.08 |
| 2015 | 9.34 | -89.64% | $108.42 | $11.61 |
| 2014 | 90.19 | -3.98% | $53.21 | $0.59 |
| 2013 | 93.93 | N/A | $52.6 | $0.56 |
| 2012 | N/A | N/A | $20.74 | -$0.03 |
| 2011 | 24.22 | N/A | $11.87 | $0.49 |
Ligand Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 25.27 | -13.93% | $199.65 | $7.9 |
| Dec 2025 | 29.36 | -61.71% | $189.07 | $6.44 |
| Sep 2025 | 76.68 | N/A | $177.14 | $2.31 |
| Jun 2025 | N/A | N/A | $113.68 | -$4.07 |
| Mar 2025 | N/A | N/A | $105.14 | -$7.2 |
| Dec 2024 | N/A | N/A | $107.15 | -$0.22 |
| Sep 2024 | 37.91 | 9.79% | $100.09 | $2.64 |
| Jun 2024 | 34.53 | 157.49% | $84.26 | $2.44 |
| Mar 2024 | 13.41 | -43.3% | $73.1 | $5.45 |
| Dec 2023 | 23.65 | -62.11% | $71.42 | $3.02 |
| Sep 2023 | 62.42 | 35.93% | $59.92 | $0.96 |
| Jun 2023 | 45.92 | -13.23% | $72.1 | $1.57 |
| Mar 2023 | 52.92 | N/A | $73.56 | $1.39 |
| Dec 2022 | N/A | N/A | $66.8 | -$1.98 |
| Sep 2022 | N/A | N/A | $86.11 | -$1.27 |
LGND Price vs fair value
LGND average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of LGND is below the 3, 5 and 10-year averages.
PE comparison
With a P/E of 35.37, LGND is above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 23.78, Ligand Pharmaceuticals's P/E is 49% higher.
LGND PE vs peers
LGND's PE ratio is lower than its peer stock LLY, but it is greater than JNJ's and MRK's. Ligand Pharmaceuticals is presently trading at a higher PE ratio (35.37) than its peer group average of 26.42.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BMY Bristol Myers Squibb Co | 15.55 | $113.4B |
| PFE Pfizer Inc | 18.87 | $140.89B |
| AMGN Amgen Inc | 23.96 | $187.28B |
| JNJ Johnson & Johnson | 27.39 | $575.52B |
| MRK Merck & Co Inc | 33.5 | $295.39B |
| LGND Ligand Pharmaceuticals Inc | 35.37 | $5.6B |
| LLY ELI LILLY & Co | 39.27 | $1.04T |
| BAX Baxter International Inc | N/A | $10.38B |
Frequently asked questions
What is Ligand Pharmaceuticals's PE ratio?
The price to earnings ratio for LGND stock is 35.37 as of Jun 23, 2026.
What is the 3-year average PE ratio for Ligand Pharmaceuticals (LGND)?
The 3-year average PE ratio for LGND stock is 38.79.
What is the 5-year average PE ratio for Ligand Pharmaceuticals (LGND)?
The 5-year average PE ratio for LGND stock is 43.25.
What is the highest PE ratio for LGND?
The highest quarterly PE ratio in the last ten years has been 794.33 and it was in the Sep 2020 quarter.
How does the current PE ratio for LGND compare to its historical average?
LGND's price to earnings ratio is currently 61% below its 10-year historical average.
How is LGND's PE ratio calculated (Ligand Pharmaceuticals PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jun 23, 2026), Ligand Pharmaceuticals's stock price is $279.44. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $7.9. Therefore, Ligand Pharmaceuticals's P/E ratio for today is 35.37. PE RATIO(35.37) = STOCK PRICE($279.44) / TTM EPS($7.9)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.